Evidence map›Paper›PMID 27052585›Full record

ArticleJournal of neurophysiology2016

Development of a spontaneously active dorsal root ganglia assay using multiwell multielectrode arrays.

Kim Newberry, Shuya Wang, Nina Hoque, Laszlo Kiss, Michael K Ahlijanian, James Herrington, John D Graef

Abstract read
In one paragraph

Article in Journal of neurophysiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. An Innervated Human Skin Equivalent that Electrically Encodes Mechanical and Thermal Stimuli.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Frontiers in public health · 2023
    Article
  12. Article
  13. Lab-on-Chip Microsystems forFrontiers in bioengineering and biotechnology · 2022
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kim NewberryGenetically Defined Diseases, Bristol-Myers Squibb Company, Wallingford, Connecticut; and.
Shuya WangGenetically Defined Diseases, Bristol-Myers Squibb Company, Wallingford, Connecticut; and.
Nina HoqueGenetically Defined Diseases, Bristol-Myers Squibb Company, Wallingford, Connecticut; and.
Laszlo KissLeads Discovery and Optimization, Bristol-Myers Squibb Company, Wallingford, Connecticut.
Michael K AhlijanianGenetically Defined Diseases, Bristol-Myers Squibb Company, Wallingford, Connecticut; and.
James HerringtonGenetically Defined Diseases, Bristol-Myers Squibb Company, Wallingford, Connecticut; and.
John D GraefGenetically Defined Diseases, Bristol-Myers Squibb Company, Wallingford, Connecticut; and john.graef@bms.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In vitro phenotypic assays of sensory neuron activity are important tools for identifying potential analgesic compounds. These assays are typically characterized by hyperexcitable and/or abnormally, spontaneously active cells. Whereas manual electrophysiology experiments provide high-resolution biophysical data to characterize both in vitro models and potential therapeutic modalities (e.g., action potential characteristics, the role of specific ion channels, and receptors), these techniques are hampered by their low throughput. We have established a spontaneously active dorsal root ganglia (DRG) platform using multiwell multielectrode arrays (MEAs) that greatly increase the ability to evaluate the effects of multiple compounds and conditions on DRG excitability within the context of a cellular network. We show that spontaneous DRG firing can be attenuated with selective Na(+) and Ca(2+) channel blockers, as well as enhanced with K(+) channel blockers. In addition, spontaneous activity can be augmented with both the transient receptor potential cation channel subfamily V member 1 agonist capsaicin and the peptide bradykinin and completely blocked with neurokinin receptor antagonists. Finally, we validated the use of this assay by demonstrating that commonly used neuropathic pain therapeutics suppress DRG spontaneous activity. Overall, we have optimized primary rat DRG cells on a multiwell MEA platform to generate and characterize spontaneously active cultures that have the potential to be used as an in vitro phenotypic assay to evaluate potential therapeutics in rodent models of pain.

Indexed as

Action PotentialsAnimalsBradykininCalcium Channel BlockersCapsaicinCells, CulturedEmbryo, MammalianFemaleGanglia, SpinalHot TemperatureMembrane Transport ModulatorsMibefradilNeuronsRatsRats, Sprague-DawleySensory System AgentsBradykininCalcium Channel BlockersCapsaicinMembrane Transport ModulatorsMibefradilSensory System AgentsSodium Channel BlockersSodium ChlorideSubstance PTetrodotoxinDRGMEAnociceptorssensoryspontaneous activity

Identifiers

PMID27052585
PMCPMC4946598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.